Drug companies still outsource to make fixed costs variable rather than to improve their public profiles according to a Deloitte analyst.
Sterigenics will triple gamma sterilisation capacity at a site in Arkansas on the back of strong demand from pharmaceutical and medical device customers.
Innovate Pharmaceuticals has launched what it claims is the world’s first shelf-stable liquid aspirin, and says it is on the look-out for a licensing partner for the “$500m” market.
Medical affairs and post-market research are fast growing opportunities for CROs according to observers who say drug companies are starting to outsource more late-phase and post approval work.
Johnson Matthey has bought Sigma-Aldrich’s Pharmorphix division to add a 'significant' customer base and expand its European API business.
Pharma M&A, complex APIs and an increasing need for flexibility are driving a €300m manufacturing network overhaul, says Vetter.